Commentary on the Carvedilol or Metoprolol European Trial (COMET)

American Journal of Cardiology

Volumn 93, Issue 9 SUPPL. 1, 2004, Pages 40-42

  Poole Wilson, Philip A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL TARTRATE;

BETA ADRENERGIC RECEPTOR BLOCKING; CAUSE OF DEATH; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; HEART FAILURE; HUMAN; MORBIDITY; MORTALITY; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW;

EID: 2442615058     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.01.005     Document Type: Article

References (22)

1. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, et al. Carvedilol or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003;362:7-13
2. Poole-Wilson P.A., Cleland J.G., Di Lenarda A., Hanrath P., Komajda M., Metra M., Remme W.J., Swedberg K., Torp-Pedersen C. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure COMET. Eur J Heart Fail. 4:2002;321-329
3. MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007
4. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure: the SOLVD Investigators. N Engl J Med 1991;325:293-302
5. COMET. Hospitalizations and predefined secondary endpoints. Presented at the Heart Failure Society of America 77th Annual Scientific Meeting Breakfast Satellite Symposium; September 22, 2003; Las Vegas, Nevada
6. Packer M., Poole-Wilson P.A., Armstrong P.W., Cleland J.G., Horowitz J.D., Massie B.M., Ryden L., Thygesen K., Uretsky B.F. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 100:1999;2312-2318
7. Sandberg A., Blomqvist I., Jonsson U.E., Lundborg P. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol a comparison with conventional tablets. Eur J Clin Pharmacol. 33:(suppl):1988;S9-S14
8. Sandberg A., Abrahamsson B., Svenheden A., Olofsson B., Bergstrand R. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing. Pharm Res. 10:1993;28-34
9. Abrahamsson B., Lucker P., Olofsson B., Regardh C.G., Sandberg A., Wieselgren I., Bergstrand R. The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects a study on conventional metoprolol and metoprolol CR/ZOK formulations. J Clin Pharmacol. 30:1990;S46-S54
10. Lucker P., Moore G., Wieselgren I., Olofsson B., Bergstrand R. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses. J Clin Pharmacol. 30:1990;S17-S27
11. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure: MOCHA Investigators. Circulation 1996;94:2807-2816
12. Andersson B., Hamm C., Persson S., Wikstrom G., Sinagra G., Hjalmarson A., Waagstein F. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 23:1994;1397-1404
13. Kukin M.L., Kalman J., Charney R.H., Levy D.K., Buchholz-Varley C., Ocampo O.N., Eng C. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation. 99:1999;2645-2651
14. Metra M., Giubbini R., Nodari S., Boldi E., Modena M.G., Dei Cas L. Differential effects of beta-blockers in patients with heart failure a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation. 102:2000;546-551
15. Di Lenarda A, Sabbadini G, Salvatore L, Sinagra G, Mestroni L, Pinamonti B, Gregori D, Ciani F, Muzzi A, Klugmann S, Camerini F. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol: the Heart-Muscle Disease Study Group. J Am Coll Cardiol 1999;33:1926-1934
16. Wikstrand J. Achieving optimal beta1-blockade with metoprolol CR/Zok. Basic Res Cardiol. 95:(suppl 1):2000;I-46-I-51
17. Sanderson J.E., Chan S.K., Yip G., Yeung L.Y., Chan K.W., Raymond K., Woo K.S. Beta-blockade in heart failure a comparison of carvedilol with metoprolol. J Am Coll Cardiol. 34:1999;1522-1528
18. Andersson B., Aberg J., Lindelow B., Tang M.S., Wikstrand J. Dose-related effects of metoprolol on heart rate and pharmacokinetics in heart failure. J Card Fail. 7:2001;311-317
19. Yue T.L., Cheng H.Y., Lysko P.G., McKenna P.J., Feuerstein R., Gu J.L., Lysko K.A., Davis L.L., Feuerstein G. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther. 263:1992;92-98
20. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 1993;342:1441-1446
21. Packer M., Coats A.J., Fowler M.B., Katus H.A., Krum H., Mohacsi P., Rouleau J.L., Tendera M., Castaigne A., Roecker E.B., Schultz M.K., DeMets D.L. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344:2001;1651-1658
22. rd Annual Scientific Sessions of the American College of Cardiology; March 7-10, 2004; New Orleans, LA.